Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.20
-0.05 (-0.61%)
At close: Oct 23, 2026, 4:00 PM EDT
9.10
+0.90 (10.98%)
After-hours: Oct 23, 2026, 7:30 PM EDT

Prothena Corporation Revenue

Prothena Corporation had revenue of $1.01M in the quarter ending June 30, 2026, a decrease of -77.15%. This brings the company's total for the last twelve months to $54.53M, up 427.32% year-over-year. In the year 2025, Prothena Corporation had annual revenue of $9.68M, down -92.83%. That makes Prothena Corporation the 27,311th largest company in the world by revenue and 3,716th in the United States.

Revenue (ttm)
$54.53M
Revenue Growth
+427.32%
P/S Ratio
7.72
Revenue / Employee
$813,881
Employees
67
Market Cap
420.96M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.68M-125.47M-92.83%
Dec 31, 2024135.16M43.79M47.92%
Dec 31, 202391.37M37.47M69.50%
Dec 31, 202253.91M-146.67M-73.13%
Dec 31, 2021200.58M199.72M23,414.30%
Dec 31, 2020853.00K39.00K4.79%
Dec 31, 2019814.00K-141.00K-14.76%
Dec 31, 2018955.00K-26.56M-96.53%
Dec 31, 201727.52M26.46M2,508.44%
Dec 31, 20161.06M-552.00K-34.35%
Dec 31, 20151.61M-49.25M-96.84%
Dec 31, 201450.85M50.18M7,422.78%
Dec 31, 2013676.00K-1.98M-74.57%
Dec 31, 20122.66M2.15M424.26%
Dec 31, 2011507.00K-736.00K-59.21%
Dec 31, 20101.24M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Autolus Therapeutics117.39M
ARS Pharmaceuticals116.93M
Assembly Biosciences74.85M
YD Bio1.24M
ProKidney818.00K
Altimmune31.00K
Revenue Rankings